logo
Surge in ‘neglected' deadly parasite that destroys your organs sparks fears it will ‘inevitably' reach the UK

Surge in ‘neglected' deadly parasite that destroys your organs sparks fears it will ‘inevitably' reach the UK

Scottish Sun25-04-2025

Read on for where the parasite has been found and telltale symptoms of the disease that can strike a decade after infection
LATEST THREAT Surge in 'neglected' deadly parasite that destroys your organs sparks fears it will 'inevitably' reach the UK
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
EXPERTS have sounded the alarm over the surge of a "neglected" parasite that can cause deadly liver failure.
Alveolar echinococcosis (AE) is a rare parasitic disease that spreads from animals to humans and is "of increasing concern worldwide" - but the recent rise in cases has sparked fears that it could reach the UK.
Sign up for Scottish Sun
newsletter
Sign up
2
Alveolar echinococcosis is characterised by tumour-like growths in the liver
Credit: Getty
2
It's caused by a parasite commonly carried by foxes
Credit: Getty
The "silently progressing and infiltrative disease" is caused by the parasite Echinococcus multilocularis, known as the fox parasite as it tends to infect foxes, as well as dogs.
While animals won't usually show any signs of infection, the parasite can cause serious illness in humans, who may pick it up from contact with fox or dog faeces or handling contaminated plants, soil or berries.
When the parasite enters the body, it can cause tumour-like growths - usually in the liver - that expand slowly over 10 to 15 years, until they cause symptoms such as stomach pain, weight loss and signs of liver failure.
Left untreated, the tapeworms may spread to other organs and can be fatal.
The World Health Organisation (WHO) previously listed AE as one of its 17 most "neglected" diseases in 2014, calling for more to be done to control it.
Swiss scientists have now revealed that cases of AE, though still rare, increased nearly three times over in a 30 year period.
They also revealed that the parasitical disease - once contained in Europe, China, Japan and Siberia - is now spreading to parts of Canada and the United States.
"Previously non-endemic regions such as North America and eastern central Europe are reporting an increasing number of AE patients," University Hospital Zurich scientists wrote in a report published by the US Centers for Disease Control and Prevention (CDC).
So far, there have been no known domestically acquired cases of E. multilocularis in the UK.
But as cases of the disease are increasingly spotted European regions, it has stoked fears that the parasite may infect animals and humans in the British Isles.
What is Rat Lungworm (Angiostrongylus) Disease-
"It is almost inevitable that E.multilocularis will be introduced into the UK," veterinary surgeon Ian Wright warned in 2016.
The recent study included all patients who were treated for AE at Zurich University Hospital between 1973 and 2022, about 334 in total.
Researchers analysed patients' symptoms at diagnosis, AE stage, the treatment strategy used and resulting outcomes, and causes of death.
In 1993, there were about two cases of AE recorded by the institution, while in 2022 that number jumped to 14.
Out of the 334 patients, 151 had some type of surgery to remove the parasites while 315 received drug therapy with the medication benzimidazole.
Over the 50-year study period, 90 patients died but mostly from causes other than the parasitic infection.
Only 13 deaths were directly caused by AE, researchers found.
Researchers also found that people who'd contracted AE had lower survival rates compared with the general population five years after diagnosis - especially those who were diagnosed with AE later in life.
Symptoms of alveolar echinococcosis (AE)
AE is caused by tumor-like or cyst-like tapeworm larvae growing in the body.
AE usually involves the liver but can spread to other organs of the body.
Because the cysts are slow-growing, infection with AE may not produce any symptoms for many years.
Pain or discomfort in the upper abdominal region, weakness, and weight loss may occur as a result of the growing cysts.
Symptoms may mimic those of liver cancer and cirrhosis of the liver.
People who accidentally swallow the eggs of the Echinococcus multilocularis tapeworm are at risk for infection.
People at high risk include trappers, hunters, veterinarians, or others who have contact with wild foxes, or coyotes, or their stool, or household dogs and cats that eat wild rodents infected with AE.
Humans can be exposed to these eggs by ingesting food contaminated with stool from foxes, such as herbs, greens, or berries, or by petting dogs or cats who have the tapeworm and then touching their mouth.
Source: CDC
But AE didn't seem to be the main driver of their shortened life expectancy.
The researchers also found that without benzimidazole therapy, 90 per cent of patients died within 10 years of contracting the disease but with long-term therapy, they were able to prevent a disease from worsening.
They also concluded that removing all of the parasite-damaged tissue in the body through surgery could improve overall survival but could not slow down the disease.
The study authors speculated that the "the gradual decline of relative survival five years after diagnosis could reflect a generally sicker population".
"In our cohort, the rise of annual AE cases was accompanied by a substantial increase in incidental findings and a shift toward earlier stages, although symptomatic patients with an advanced disease stage remained the majority," report authors said.
Alveolar echinococcosis in the UK
While there have been no known domestically acquired cases of E. multilocularis in the UK, the parasitic disease was the cause of death of a woman in 1954, according to the British Pest Control Association.
She had never left the country but is thought to have picked up the parasite after eating unpasteurised Swiss cheese.
A further case was reported in 2002 in a man from Afghanistan who had recently moved to the UK from Pakistan.
In 2022, 27 European countries reported 731 echinococcosis cases, according to the European Centre for Disease Prevention and Control (ECDC).
In the last decade, cases have doubled in France, Germany, Austria and Switzerland.
Baltic countries have also seen an increase in cases, while the disease has become established in regions of Denmark, Sweden, Norway, and the north-western coast of France.
The only countries currently free of E. multilocularis are the UK, Ireland, Malta and Finland.
To remain disease-free, all them conduct yearly fox surveillance programmes for the parasite and report their findings to the European Commission once a year.
There is a risk that dogs who travel with their owners to regions where the parasite is endemic could pick up the parasite.
Writing in Improve Veterinary Practice, Ian Wright said: "The Pet travel scheme currently still requires dogs to be treated with praziquantel between one and five days before entry to the UK.
"This simple treatment has currently prevented endemic foci from developing, and as such it remains vital.
"It has been demonstrated that if this compulsory treatment is abandoned altogether, then it is almost inevitable that E.multilocularis will be introduced into the UK.
"For every 10,000 dogs travelling on a short visit to an endemic country such as Germany, the probability of at least one returning with the parasite is approximately 98 per cent.
"This probability increases to over 99 per cent if dogs have been longer term residents.
"Although the one to five day rule has provided protection against this, it does allow a window of opportunity for infection.
"If E.multilocularis is allowed entry into the UK, the large fox and microtine vole population will make the prevention of endemic E.multilocularis difficult, if not impossible to achieve."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Vicky Pattison terrified as she's overcome with ‘crippling anxiety, insomnia and dark thoughts' during PMDD episode
Vicky Pattison terrified as she's overcome with ‘crippling anxiety, insomnia and dark thoughts' during PMDD episode

Scottish Sun

timean hour ago

  • Scottish Sun

Vicky Pattison terrified as she's overcome with ‘crippling anxiety, insomnia and dark thoughts' during PMDD episode

The star previously told how she was "fobbed off for years" by male doctors over her condition VICKY'S JOURNEY Vicky Pattison terrified as she's overcome with 'crippling anxiety, insomnia and dark thoughts' during PMDD episode VICKY Pattison has bravely revealed how she was left terrified after she was overcome with "crippling anxiety, insomnia and dark thoughts" during her latest PMDD episode. The former Geordie Shore star, 37, has often spoken out about her experience of the chronic health condition, in a bid to help other people who also suffer. Advertisement 5 Vicky Pattison opened up about her recent PMDD episode which saw her have 'dark thoughts' Credit: Instagram 5 Vicky revealed how bloated she gets during an episode Credit: Instagram 5 Vicky wanted to share the highs and lows of her life with PMDD Credit: Getty Vicky has been very honest about the mental health aspect of premenstrual dysphoric disorder (PMDD). Last night, she shared a very open and honest video about how the condition affects her life for one week of every month. In the video she showed the bad times during a PMDD episode, and also the extreme highs that she feels. Vicky was also seen revealing how bloated her stomach gets during her times of pain. Advertisement In parts of the video she is crying, while others she is dancing. In her lengthy, emotional caption, Vicky wrote: "he highs & lows of PMDD. "It's always a bit of a mixed bag with my PMDD- some months aren't so bad & I feel hopeful. "And other months it just completely takes me out & I feel hopeless. Usually there's no real rhyme or reason. Advertisement "But last month I knew I was in for a bit of a rough ride- I hadn't done anything that I know helps alleviate my symptoms. I hadn't been consistent with my supplements, my diet was atrocious & my schedule was just unrelenting so I went into my luteal phase not really standing a chance. "But despite my concerns, nothing could have prepared me. It was terrifying." Former winner Vicky Pattinson sends I'm A Celeb cast a warning about life after the jungle - as they arrive back in UK Vicky then went onto detail how much her PMDD had affected her last month. "I rang my sister and told her that I didn't know what I was going to do - that I genuinely didn't know what I was capable of," she told fans. Advertisement "And after a week of crippling anxiety, insomnia, my inner critic finding fault at every turn & dark thoughts...I know I meant it." Continuing she said: "And that's the thing with PMDD, one week you're this bright, shiny, brilliant woman who is strong, smart & ready for anything life throws at you.. & then your PMDD fog sets in and your brain convinces you that you're worthless." What is PMDD? Premenstrual Dysphoric Disorder (PMDD) is a severe and chronic medical condition that affects a small percent of people who menstruate. It is a more intense form of premenstrual syndrome (PMS) and is characterised by a range of emotional, mental, and physical symptoms that can significantly disrupt daily life. Unlike PMS, which might cause mild discomfort or irritability, PMDD symptoms can be debilitating and often require medical attention. The exact cause of PMDD is not fully understood, but it is believed to be linked to hormonal changes that occur during the menstrual cycle, particularly fluctuations in oestrogen and progesterone. These hormonal shifts can affect neurotransmitters in the brain, such as serotonin, which plays a critical role in mood regulation. Genetic factors may also contribute to the development of PMDD, as the disorder tends to run in families. Symptoms of PMDD typically appear in the luteal phase of the menstrual cycle, which is the time between ovulation and the start of menstruation. Common symptoms include severe mood swings, depression, irritability, anxiety, and feelings of hopelessness. Physical symptoms can also manifest, such as fatigue, bloating, breast tenderness, and headaches. These symptoms usually subside once menstruation begins, providing temporary relief until the next cycle. Treatment for PMDD often involves a combination of lifestyle changes, medication, and therapy. Lifestyle adjustments, such as regular exercise, a balanced diet, and adequate sleep, can help manage symptoms. Medications like selective serotonin reuptake inhibitors (SSRIs) and hormonal treatments may also be prescribed to alleviate the disorder's impact. Cognitive behavioural therapy (CBT) can be beneficial in addressing the emotional and psychological aspects of PMDD, offering coping strategies and support. But Vicky added: "I'm telling this story, not for sympathy, but because I know I'm not alone. "I want anyone dealing with PMDD, anyone feeling the things I did last month to know that you are not alone and regardless of what your brain is telling you - you are an incredible person & world is better for having you in it. Advertisement "The fog, the darkness & the depression will pass and in its place will be beautiful moments, happiness, success, pure unfiltered JOY! "You are a warrior.. you are powerful & you are UNSTOPPABLE." 5 The reality star has kept fans-updated with her on going battle Credit: vickypattison/Instagram 'FOBBED OFF' BY DOCTORS Vicky previously told how she was "fobbed off for years" by male doctors over her condition. Advertisement She told ITV's Good Morning Britain the condition made you feel 'the world would be a better place without you in it'. She added: 'For five years I was dismissed. I was made to feel ashamed. "For the majority of the time it was men. 'I think they lack an understanding and empathy towards what we're going through as women. Advertisement "They are not given the correct, I think, information, education to be able to treat a woman going through what those women are." Vicky also admitted her "depressed and hopeless" state of mind shortly prior to her wedding this year, as the condition took hold.

Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z
Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z

Scottish Sun

time9 hours ago

  • Scottish Sun

Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z

Doctors say heavy use can cause liver disease and permanently damage the bladder and kidneys GENERATION K Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z DOCTORS have sounded the alarm over an eight-fold rise in ketamine addiction in a decade. The powerful tranquilliser is popular with Generation Z because of its relatively low cost, experts say. Advertisement 1 Addiction to ketamine has risen eight-fold in a decade, experts have warned Credit: Getty Clinics in England treated 3,609 people of all ages for addiction last year, eight times more than 426 in 2014, figures reveal. Ketamine, also referred to as 'K' or 'Ket', numbs pain and can cause a trippy high. Dealers sell it in powder form for around £20 to £40 a gram compared with £40 to £60 a gram for low-quality cocaine. Doctors say heavy use can cause liver disease and permanently damage the bladder and kidneys. It is linked to constipation, depression and loss of mental sharpness. Advertisement Many medics fail to understand how addictive it can be, an NHS report said. Led by Dr Irene Guerrini of the South London and Maudsley NHS Trust, it called the drug's prevalence 'concerning'. It said: 'As ketamine use increases, more individuals are seeking treatment for addiction. 'Long-term use can seriously harm both physical and mental health, diminishing quality of life, affecting personal relationships and impairing academic or professional performance.' Advertisement Dr Guerrini called for stricter guidelines on how the NHS uses the drug and more funds for treatment and prevention. Ministers are considering uprating 34878330from a Class B to Class A drug.

Taking common contraceptive pill long-term could increase your risk of life-threatening brain tumour, scientists warn
Taking common contraceptive pill long-term could increase your risk of life-threatening brain tumour, scientists warn

Scottish Sun

time10 hours ago

  • Scottish Sun

Taking common contraceptive pill long-term could increase your risk of life-threatening brain tumour, scientists warn

Find out all the pros and cons of the contraceptive pill below BITTER PILL Taking common contraceptive pill long-term could increase your risk of life-threatening brain tumour, scientists warn TAKING a progesterone-only contraceptive pill for more than five years is linked to an increased risk of a life-threatening brain tumour, say scientists. Desogestrel is a synthetic progestogen hormone used in oral contraceptives, specifically the progestogen-only pill (POP) or mini-pill. 1 Long-term use of desogestrel has been linked to intracranial meningiomas Credit: Science Photo Library - Getty While it offers several benefits beyond preventing pregnancy, such as regulating the menstrual cycle, reducing heavy or painful periods, new research suggests taking it continuously for more than five years is linked to a small increased risk of developing an intracranial meningioma. An intracranial meningioma is a tumour that develops from the meninges, the layers of tissue that cover the brain and spinal cord. These tumours are typically benign (non-cancerous) and slow-growing. But they can be life-threatening depending on size, location, and growth rate. The tumours are more common in older women, but previous studies lack information on the specific type of progestogen used - and risk has not been measured for continuous, current, and long term use. In the study from France published by The BMJ, researchers set out to assess the real-life risk of the brain tumour and short-term (less than a year) and prolonged (one to seven or more years) use of oral contraceptives containing desogestrel 75µg, levonorgestrel 30µg, or levonorgestrel 50-150 µg combined with oestrogen. Their findings were based on data from the French national health data system (SNDS) for 8,391 women who had undergone surgery for intracranial meningioma in 2020-2023. Each case was matched to 10 control women without meningioma of the same age and area of residence. The results showed a small increased risk associated with use of desogestrel for more than five continuous years. An increased risk wasn't found for shorter durations or when desogestrel had been discontinued for more than one year. Women taking fat jabs need 'effective contraception' - as health chiefs warn of serious harm to unborn babies The risk was greater in women older than 45 and after prolonged use of one of the known high risk progestogens before desogestrel. Although the researchers added the risk disappeared one year after stopping taking the pill. It was estimated that 67,000 women would need to use desogestrel for one woman to need surgery for intracranial meningioma, and 17,000 women if current use was for more than five years. No increased risk was found for levonorgestrel, alone or combined with oestrogen, regardless of duration of use. The researchers suggested desogestrel be discontinued if an intracranial meningioma is identified and patients monitored rather than undergoing immediate surgery.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store